Sensyne Health Plc (Sensyne), formerly Sensyne Health Ltd, is a digital healthcare company that develops regulated medical products and services using artificial intelligence.

The company uses its proprietary clinical artificial intelligence technology to analyse ethically sourced, clinically curated, anonymised patient data in partnership with NHS Foundation Trusts to solve unmet medical needs across a range of therapeutic areas.

Its products include clinically validated SEND, an early warning system; GDm-Health, a digital diabetes management system; EDGE, a digital chronic obstructive pulmonary disease management system; and CleanSpace, an air pollution monitoring application.

Sensyne is headquartered in Oxford, Oxfordshire, UK.